Jingcheng Zhang

Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Tumor-educated adipocytes promote muscle wasting via EV-packaged miR-221-3p targeting IRS1 in pancreatic cancer cachexia.

Tumor-educated adipocytes promote muscle wasting via EV-packaged miR-221-3p targeting IRS1 in pancreatic cancer cachexia.

Journal: Cancer letters

Published: March 18, 2026

Pancreatic Intraductal Papillary Mucinous Neoplasm With Invasive Carcinoma Concomitant With Ampullary Neuroendocrine Tumor: A Case Report.

Pancreatic Intraductal Papillary Mucinous Neoplasm With Invasive Carcinoma Concomitant With Ampullary Neuroendocrine Tumor: A Case Report.

Journal: Clinical case reports

Published: May 08, 2025

Pancreatic ductal adenocarcinoma chemoresistance: From metabolism reprogramming to novel treatment.

Pancreatic ductal adenocarcinoma chemoresistance: From metabolism reprogramming to novel treatment.

Journal: Chinese medical journal

Published: March 28, 2023

Metastatic insulinoma: exploration from clinicopathological signatures and genetic characteristics.

Metastatic insulinoma: exploration from clinicopathological signatures and genetic characteristics.

Journal: Frontiers in oncology

Published: November 27, 2022

Pesticide screening and health risk assessment of residential dust in a rural region of the North China Plain.

Pesticide screening and health risk assessment of residential dust in a rural region of the North China Plain.

Journal: Chemosphere

Published: March 14, 2022

Effects of Pymetrozine and Tebuconazole with Foliar Fertilizer Through Mixed Application on Plant Growth and Pesticide Residues in Cucumber.

Effects of Pymetrozine and Tebuconazole with Foliar Fertilizer Through Mixed Application on Plant Growth and Pesticide Residues in Cucumber.

Journal: Bulletin of environmental contamination and toxicology

Published: April 05, 2021

Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors.

Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors.

Journal: Scientific reports

Published: January 29, 2020

MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations.

MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations.

Journal: Frontiers in oncology

Published: July 11, 2019

Refinement of diagnosis and supporting evidence for the use of immunotherapy through sequential biopsies in a case of EML4-ALK positive lung cancer.

Refinement of diagnosis and supporting evidence for the use of immunotherapy through sequential biopsies in a case of EML4-ALK positive lung cancer.

Journal: OncoTargets and therapy

Published: January 28, 2019

Curative effect assessment of immunotherapy for non-small cell lung cancer: The "blind area" of Immune Response Evaluation Criteria in Solid Tumors (iRECIST).

Curative effect assessment of immunotherapy for non-small cell lung cancer: The "blind area" of Immune Response Evaluation Criteria in Solid Tumors (iRECIST).

Journal: Thoracic cancer

Published: December 07, 2018

Real-world evidenceand clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors.

Real-world evidenceand clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors.

Journal: Scientific reports

Published: October 24, 2018

Alectinib treatment response in lung adenocarcinoma patient with novel EML4-ALK variant.

Alectinib treatment response in lung adenocarcinoma patient with novel EML4-ALK variant.

Journal: Thoracic cancer

Published: May 31, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026